Trough Level Targeting

Trough Level Targeting is a pharmacokinetic strategy within mTOR inhibitor therapy that involves adjusting drug dosages to maintain plasma concentrations at a predetermined minimum level immediately before the next administration, thereby optimizing therapeutic efficacy while minimizing toxicity.

16

Publications

1.2K

Citations

111

Authors

48

Institutions

Publications per year

2017–2026

6

Variants

Trough-level-guided Dosing

Authors

111

  1. OK
    Osamu Konno

    Tokyo Medical University Hachioji Medical Center, Japan

    2 publications · 35 citations

    2

    h-index

  2. TH
    Toshihiko Hirano

    Tokyo University of Pharmacy and Life Sciences, Japan

    2 publications · 35 citations

    2

    h-index

  3. HI
    Hitoshi Iwamoto

    Tokyo Medical University Hachioji Medical Center, Japan

    2 publications · 35 citations

    2

    h-index

  4. NM
    Naoto Matsuno

    Tokyo Medical University Hachioji Medical Center, Japan

    2 publications · 35 citations

    2

    h-index

  5. HT
    Hirohito Takeuchi

    Tokyo Medical University, Japan

    2 publications · 35 citations

    2

    h-index

1–5 of 111

Venues

  1. Haemophilia

    3 publications · 113 citations

    3

    h-index

  2. Transplantation Proceedings

    2 publications · 35 citations

    2

    h-index

  3. American Journal of Transplantation

    1 publications · 57 citations

    1

    h-index

  4. Digestive and Liver Disease

    1 publications · 14 citations

    1

    h-index

  5. Hämostaseologie

    1 publications · 15 citations

    1

    h-index

1–5